Aspire Biopharma Holdings, Inc. (ASBP)
8.95
+0.34
(+3.95%)
USD |
NASDAQ |
Sep 10, 15:53
Aspire Biopharma Holdings Enterprise Value : -1.015M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | -1.015M |
| September 08, 2026 | -0.7046M |
| September 04, 2026 | -0.6787M |
| September 03, 2026 | -0.1865M |
| September 02, 2026 | -0.2448M |
| September 01, 2026 | -0.6269M |
| August 31, 2026 | -0.5362M |
| August 28, 2026 | -1.145M |
| August 27, 2026 | -1.469M |
| August 26, 2026 | -1.378M |
| August 25, 2026 | -1.456M |
| August 24, 2026 | -2.052M |
| August 21, 2026 | -1.844M |
| August 20, 2026 | -2.039M |
| August 19, 2026 | -1.935M |
| August 18, 2026 | -2.272M |
| August 17, 2026 | -2.142M |
| August 14, 2026 | -2.000M |
| August 13, 2026 | -2.958M |
| August 12, 2026 | -2.932M |
| August 11, 2026 | -2.311M |
| August 10, 2026 | -2.078M |
| August 07, 2026 | -2.155M |
| August 06, 2026 | -3.023M |
| August 05, 2026 | -2.764M |
| Date | Value |
|---|---|
| August 04, 2026 | -3.049M |
| August 03, 2026 | -2.803M |
| July 31, 2026 | -3.722M |
| July 30, 2026 | -3.463M |
| July 29, 2026 | -4.901M |
| July 28, 2026 | -2.783M |
| July 27, 2026 | -3.140M |
| July 24, 2026 | -2.764M |
| July 23, 2026 | -2.829M |
| July 22, 2026 | -2.116M |
| July 21, 2026 | -2.401M |
| July 20, 2026 | -3.645M |
| July 17, 2026 | -4.085M |
| July 16, 2026 | -4.033M |
| July 15, 2026 | -4.344M |
| July 14, 2026 | -4.357M |
| July 13, 2026 | -4.435M |
| July 10, 2026 | -4.383M |
| July 09, 2026 | -4.305M |
| July 08, 2026 | -4.681M |
| July 07, 2026 | -4.901M |
| July 06, 2026 | -4.551M |
| July 02, 2026 | -4.124M |
| July 01, 2026 | -4.577M |
| June 30, 2026 | -5.251M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Resonate Blends, Inc. | 5.797M |
| Breakthrough Chemistry, Inc. | 1.506M |
| Kaya Holdings, Inc. | -- |
| Cardiac Biotech Solutions, Inc. | 6.576M |
| Endexx Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.268M |
| Revenue (Quarterly) | 0.0631M |
| Total Expenses (Quarterly) | 1.331M |
| EPS Diluted (Quarterly) | -1.222 |
| Gross Profit Margin (Quarterly) | 19.49% |
| Profit Margin (Quarterly) | -2.01K% |
| Earnings Yield | -1.19K% |
| Normalized Earnings Yield | -1571.19 |